Regeneron Pharmaceuticals, Inc (REGN) Stock Price

760.365 ▲ +10.895 (+1.45%)
Open: 749.15 Vol: 0 Day's range: 749.15 - 761.51 Mar 26, 14:04 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
REGN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 760.77▼ 760.24▲ 759.14▲ 744.25▲ 756.17▲
MA10 760.70▼ 758.91▲ 754.35▲ 746.46▲ 764.42▼
MA20 760.33▲ 754.42▲ 747.31▲ 759.54▲ 759.61▲
MA50 758.78▲ 745.19▲ 743.61▲ 763.85▼ 644.60▲
MA100 754.68▲ 745.02▲ 753.49▲ 749.46▲ 765.96▼
MA200 748.45▲ 754.12▲ 767.15▼ 656.82▲ 771.41▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.081▼ 0.299▲ 1.696▲ -0.561▼ -7.266▼
RSI 57.212▲ 72.310▲ 69.615▲ 50.777▲ 55.878▲
STOCH 70.511     87.147▲ 84.040▲ 32.827     40.443    
WILL %R -28.901     -6.128▲ -3.378▲ -46.037     -58.810    
CCI 51.149     84.625     122.514▲ 20.599     -82.827    
Latest Filters Detected On REGN
RSI $REGN RSI(14) Crossed Above 50 Set Alert
MA $REGN Price Crossed Above MA(13) Set Alert
CDL $REGN Marubozu Candlestick Pattern Detected Set Alert
Regeneron Pharmaceuticals, Inc News
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2026
Wednesday, March 25, 2026 01:19 PM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its first quarter 2026 financial and operating results on Wednesday, April 29, 2026, before the U.S. financial ...
REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria
Monday, March 02, 2026 06:10 AM
Regeneron Pharmaceuticals REGN and its partner Sanofi SNY announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion ...
Barclays Initiates Coverage of Regeneron Pharmaceuticals (REGN) with Overweight Recommendation
Wednesday, February 25, 2026 04:00 PM
As of February 26, 2026, the average one-year price target for Regeneron Pharmaceuticals is $874.36/share. The forecasts range from a low of $666.60 to a high of $1,109.85. The average price target ...
REGN historical stock data
date open high low close volume
26/03/26 748.73 761.51 748.73 760.695 145,803
25/03/26 744.67 757.98 744.02 749.47 553,100
24/03/26 732.51 743.165 727.97 741.69 507,714
23/03/26 740.50 750.00 735.395 736.53 510,002
20/03/26 738.17 744.85 728.64 732.87 1,325,256
19/03/26 744.50 750.315 727.88 737.45 627,087
18/03/26 751.22 757.60 734.56 744.12 672,500
17/03/26 763.53 771.23 755.64 759.05 437,000
16/03/26 750.00 763.30 747.0101 756.91 395,717
13/03/26 754.55 758.98 741.90 745.77 438,100
Quote Details
52wk Low:476.49
52wk High:821.11
Vol:0
Avg Vol(3m):14.4M
1Y Chng:+37.26%
1M Chng:-2.93%
Add to Watch List
More Information
Market Cap. 78.41B